Skip to navigation

If you're reading this, it may be time to upgrade your browser.

Faculty

Leonard E. Weisman, M.D.

Leonard E. Weisman, M.D.

Academic Appointments

  • Professor of Pediatrics—Neonatology

Clinical Titles

  • Director, Texas Children's Hospital Perinatal Center

Board Certifications

  • Pediatrics
  • Neonatal-Perinatal Medicine

Current Positions in Professional Organizations

  • Member, Advisory Board, Ronald McDonald House Houston
  • Member, Perinatal Infections Committee, World Association of Perinatal Medicine
  • Member, Committee on Maternal and Prenatal Health, Texas Medical Association
  • Alternate Delegate, Texas Medical Association House of Delegates
  • Member, Committee on Fetus and Newborn, Texas Pediatric Society
  • Member, Committee on Legislation, Texas Pediatric Society
  • Trustee, West Point Jewish Chapel Fund

Professional History

  • M.D., Baylor College of Medicine, Houston TX, 1974
  • Pediatric Intern, Fitzsimons Army Medical Center, Aurora CO, 1974–1975
  • Pediatric Resident, Fitzsimons Army Medical Center, Aurora CO, 1975–1977
  • Neonatal-Perinatal Medicine Fellow, Fitzsimons Army Medical Center, Aurora CO, 1979–1981

Academic Interests

  • Laboratory studies evaluating the impact of immune modulators on common perinatal infections (eg, Streptococcus, Staphylococcus, Ureaplasma, Candida, etc.)
  • Clinical studies of the epidemiology, pathology, pathophysiology, and microbiology, of common perinatal infections, and the effectivenes of prevention or treatment strategies

Recent Publications

  1. Weisman LE. Ureaplasma and preterm birth. Progres en Neonatologie 2007; 27:483���490.
  2. Weisman LE, Fischer GW, Thackray HM, Johnson KE, Schuman RF, Mandy GT, Stratton BE, Adams KM, Mond JJ. Safety and Pharmacokinetics of an Anti-Lipoteichoic Acid Monoclonal Antibody. International Immunopharmacology. 2009 9:639-44
  3. Placencia FX, Kong L, Weisman LE. Treatment of Methicillin Resistant Staphylococcus aureus in Neonates : Lysostaphin versus Vancomycin. Pediatric Research. 2009 65(4):420-4.
  4. Weisman LE, Thackray HM, Garcia-Prats JA, Nesin M, Schneider JH,�� Fretz J, Kokai-Kun J, Mond JJ, Kramer WG, Fischer GW. Phase I/II Double Blind, Placebo Controlled, Dose Escalation, Safety and Pharmacokinetics Study in Very Low Birth Weight Neonates of Pagibaximab (BSYX-A110), an Anti-Staphylococcal Monoclonal Antibody for the Prevention of Staphylococcal Bloodstream Infections. Antimicrobial Agents and Chemotherapy. 2009 53(7):2879-86.
  5. Walls SA, Kong L, Leeming HA, Placencia FX, Popek EJ, Weisman LE. Antibiotic Prophylaxis Improves Ureaplasma Associated Lung Disease. Pediatric Research. 2009 66(2):197-201